Corcept Therapeutics Incorporated
CORT
$115.70
$1.721.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -58.71% | -64.67% | -29.43% | -25.18% | 6.09% |
| Total Depreciation and Amortization | 28.04% | 25.14% | 41.47% | 62.72% | 101.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 402.59% | 231.56% | 309.39% | 747.67% | 70.03% |
| Change in Net Operating Assets | -175.89% | -12.25% | -103.09% | 266.31% | 362.26% |
| Cash from Operations | -39.86% | -32.82% | -28.39% | 13.52% | 47.42% |
| Capital Expenditure | -44.97% | 86.47% | 90.29% | 86.25% | -323.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 51.63% | 145.89% | 139.88% | 118.62% | 75.49% |
| Cash from Investing | 47.16% | 145.10% | 139.28% | 117.93% | 74.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 23.29% | 150.89% | 165.08% | 152.22% | 163.79% |
| Repurchase of Common Stock | 44.79% | -163.78% | -547.59% | -576.48% | -1,282.64% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 53.14% | -165.95% | -677.33% | -741.54% | -2,781.96% |
| Foreign Exchange rate Adjustments | -138.30% | 513.08% | 732.46% | 35.09% | 26,300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 132.09% | 131.57% | 9.08% | -147.67% | 40.98% |